As on date of publishing, this report will capture the impact assessment of COVID-19 on this market and the same will be considered in our market forecast model. Clients purchasing this report between April and June 2020 will be getting a ‘free’ updated market data excel sheet between July and September 2020 accounting for the impact of COVID-19 on the market in the current year 2020 and forecast.

Global therapeutic drug monitoring market is expected to grow at a steady rate during the forecast period. The growing need of drug profiling for various medications such as anti-epileptics, immunosuppressants, and antibiotics is the major factor for the growth of therapeutic drug monitoring market. TDM or therapeutic drug monitoring is the primary diagnostic tool that is used to deliver an optimized dose of the drugs to define drug concentration range in blood or plasma. Therapeutic drug monitoring applications include the diagnosis of toxicity and identification and subsequent tailoring of optimal drug dose. Therapeutic drug monitoring also helps in diagnosing the cause of failed therapy outcomes and it can refine patient care by adjusting the drug dosage for better outcomes. The major drivers for therapeutic drug monitoring include increasing demand for genetic testing, increased government and private sector participation in therapeutic drug monitoring market and rise in drug profiling. The growth of the market is driven by the rising number of organ transplant procedures and the use of TDM in traditional anticancer therapies. TDM services are not cost-effective which is a restraint factor for the growth of the market.

The global therapeutic drug monitoring market is segmented based on technology, drug class, active ingredient, end user, product, company and region. Based on technology, immunoassays are expected to be the dominant segment in the forecast period. Immunoassays are easy to perform and do not require specialized training. Based on drug class, antiepileptic drugs are expected to be the dominant segment in the forecast period. These are most frequently monitored class of drugs due to their narrow therapeutic range and challenging pharmacokinetics.

Regionally, North America is expected to dominate the market in the forecast period. High rate of organ transplantation and gradual adoption of metabolite measuring procedures is the major driving factor for the growth of TDM market in the region. Asia Pacific is the second largest region which is expected to dominate the market share in the forecast period. The continuous efforts of government to provide low cost services with the aim of promoting dosage patterns is the driving factor for growth of TDM market in Asia Pacific.

Major players operating in the global therapeutic drug monitoring market include Abbott Laboratories, F Hoffmann-La Roche, Danaher Corporation, Thermo Fisher Scientific, Siemens Healthinners, Buhlmann Laboratories, Biomerieux, ARK Diagnostics, Inc., SJK Global, LLC, Meridian Healthcare S.R.L., Randox Laboratories Ltd., Sekisui Medical Co. Ltd., North American Science Associates, Inc., Alfa Scientific Designs, Inc.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021–2025

Objective of the Study:

  • To analyze and estimate the market size of global therapeutic drug monitoring market from 2015 to 2018.
  • To estimate and forecast the market size of global therapeutic drug monitoring market from 2019 to 2025 and growth rate until 2025.
  • To classify and forecast global therapeutic drug monitoring market based on technology, drug class, active ingredient, end-user, product, company and regional distribution.
  • To identify dominant region or segment in the global therapeutic drug monitoring market.
  • To identify drivers and challenges for global therapeutic drug monitoring market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in global therapeutic drug monitoring market.
  • To identify and analyze the profile of leading players operating in global therapeutic drug monitoring market.
  • To identify key sustainable strategies adopted by market players in global therapeutic drug monitoring market.

   

Click here to download the sample

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of manufacturers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of global therapeutic drug monitoring market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • Therapeutic drug monitoring manufacturers, distributors and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to therapeutic drug monitoring
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as manufacturers, suppliers, partners, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, global therapeutic drug monitoring market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Global Therapeutic Drug Monitoring Market, By Technology:
    • Immunoassays
    • Proteomic Technologies
  • Global Therapeutic Drug Monitoring Market, By Drug Class:
    • Antiarrhythmic Drugs
    • Immunosuppressants
    • Antiepileptic Drugs
    • Others
  • Global Therapeutic Drug Monitoring Market, By Active Ingredient:
    • Amikacin
    • Caffeine
    • Carbamazepine
    • Cyclosporine
    • Digitoxin
    • Digoxin
    • Disopyramide
    • Ethosuxamide
    • Gentamicin
    • Lidocaine
    • Lithium
    • Mithotrexate
    • NAPA
    • Phenobarbital
    • Quinidine
    • Sirolimus
    • Tacrolimus
    • Vancomycin
    • Others
  • Global Therapeutic Drug Monitoring Market, By End User:
    • Hospitals
    • Diagnostic Centres
    • Others     
  •  Global Therapeutic Drug Monitoring Market, By Product:
    • Immunoassay Equipment
    • Reagents
    • Other Consumables
  • Global Therapeutic Drug Monitoring Market, By Region:
    • North America
      • United States
      • Canada
      • Mexico
    • Europe
      • Germany
      • France
      • United Kingdom
      • Italy
      • Spain
    • Asia-Pacific
      • China
      • Japan
      • India
      • South Korea
      • Singapore
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
    • South America
      • Brazil
      • Argentina
      • Colombia

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in global therapeutic drug monitoring market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).
Global therapeutic drug monitoring market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com  

In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com

1.    Product Overview

2.    Research Methodology

3.    Impact of COVID-19 on Global Therapeutic Drug Monitoring Market

4.    Executive Summary

5.    Voice of Customer

6.    Global Therapeutic Drug Monitoring Market Outlook

6.1.  Market Size & Forecast

6.1.1.     By Value

6.2.  Market Share & Forecast

6.2.1.     By Technology (Immunoassays, Proteomic Technologies)

6.2.2.     By Drug Class (Antiarrhythmic Drugs, Immunosuppressants, Antiepileptic Drugs, Others)

6.2.2.1.         By Active Ingredient (Amikacin, Caffeine, Carbamazepine, Cyclosporine, Digitoxin, Digoxin, Disopyramide, Ethosuxamide, Gentamicin, Lidocaine, Lithium, Methotrexate, NAPA, Phenobarbital, Quinidine, Sirolimus, Tacrolimus, Vancomycin, Others)

6.2.3.     By End-User (Hospitals, Diagnostic Centres, Others)

6.2.4.     By Product (Immunoassay Equipment, Reagents, Other Consumables)

6.2.5.     By Company (2019)

6.2.6.     By Region

6.3.  Product Market Map

7.    Asia-Pacific Therapeutic Drug Monitoring Market Outlook

7.1.  Market Size & Forecast          

7.1.1.     By Value

7.2.  Market Share & Forecast

7.2.1.     By Technology

7.2.2.     By Drug Class

7.2.2.1.         By Active Ingredient

7.2.3.     By End-User

7.2.4.     By Product

7.2.5.     By Country

7.2.6.     Competition Outlook

7.3.  Asia-Pacific: Country Analysis

7.3.1.     China Therapeutic Drug Monitoring Market Outlook

7.3.1.1.         Market Size & Forecast

7.3.1.1.1.             By Value

7.3.1.2.         Market Share & Forecast

7.3.1.2.1.             By Technology

7.3.1.2.2.             By Drug Class

7.3.1.2.3.             By End-User

7.3.2.     India Therapeutic Drug Monitoring Market Outlook

7.3.2.1.         Market Size & Forecast

7.3.2.1.1.             By Value

7.3.2.2.         Market Share & Forecast

7.3.2.2.1.             By Technology

7.3.2.2.2.             By Drug Class

7.3.2.2.3.             By End-User

7.3.3.     Japan Therapeutic Drug Monitoring Market Outlook

7.3.3.1.         Market Size & Forecast

7.3.3.1.1.             By Value

7.3.3.2.         Market Share & Forecast

7.3.3.2.1.             By Technology

7.3.3.2.2.             By Drug Class

7.3.3.2.3.             By End-User

7.3.4.     South Korea Therapeutic Drug Monitoring Market Outlook

7.3.4.1.         Market Size & Forecast

7.3.4.1.1.             By Value

7.3.4.2.         Market Share & Forecast

7.3.4.2.1.             By Technology

7.3.4.2.2.             By Drug Class

7.3.4.2.3.             By End-User

7.3.5.     Singapore Therapeutic Drug Monitoring Market Outlook

7.3.5.1.         Market Size & Forecast

7.3.5.1.1.             By Value

7.3.5.2.         Market Share & Forecast

7.3.5.2.1.             By Technology

7.3.5.2.2.             By Drug Class

7.3.5.2.3.             By End-User

8.    Europe Therapeutic Drug Monitoring Market Outlook

8.1.  Market Size & Forecast          

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Technology

8.2.2.     By Drug Class

8.2.2.1.         By Active Ingredient

8.2.3.     By End-User

8.2.4.     By Product

8.2.5.     By Country

8.2.6.     Competition Outlook

8.3.  Europe: Country Analysis

8.3.1.     France Therapeutic Drug Monitoring Market Outlook

8.3.1.1.         Market Size & Forecast

8.3.1.1.1.             By Value

8.3.1.2.         Market Share & Forecast

8.3.1.2.1.             By Technology

8.3.1.2.2.             By Drug Class

8.3.1.2.3.             By End-User

8.3.2.     Germany Therapeutic Drug Monitoring Market Outlook

8.3.2.1.         Market Size & Forecast

8.3.2.1.1.             By Value

8.3.2.2.         Market Share & Forecast

8.3.2.2.1.             By Technology

8.3.2.2.2.             By Drug Class

8.3.2.2.3.             By End-User

8.3.3.     United Kingdom Therapeutic Drug Monitoring Market Outlook

8.3.3.1.         Market Size & Forecast

8.3.3.1.1.             By Value

8.3.3.2.         Market Share & Forecast

8.3.3.2.1.             By Technology

8.3.3.2.2.             By Drug Class

8.3.3.2.3.             By End-User

8.3.4.     Italy Therapeutic Drug Monitoring Market Outlook

8.3.4.1.         Market Size & Forecast

8.3.4.1.1.             By Value

8.3.4.2.         Market Share & Forecast

8.3.4.2.1.             By Technology

8.3.4.2.2.             By Drug Class

8.3.4.2.3.             By End-User

8.3.5.     Spain Therapeutic Drug Monitoring Market Outlook

8.3.5.1.         Market Size & Forecast

8.3.5.1.1.             By Value

8.3.5.2.         Market Share & Forecast

8.3.5.2.1.             By Technology

8.3.5.2.2.             By Drug Class

8.3.5.2.3.             By End-User

9.    North America Therapeutic Drug Monitoring Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Technology

9.2.2.     By Drug Class

9.2.2.1.         By Active Ingredient

9.2.3.     By End-User

9.2.4.     By Product

9.2.5.     By Country

9.2.6.     Competition Outlook

9.3.  North America: Country Analysis

9.3.1.     United States Therapeutic Drug Monitoring Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Technology

9.3.1.2.2.             By Drug Class

9.3.1.2.3.             By End-User

9.3.2.     Mexico Therapeutic Drug Monitoring Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Technology

9.3.2.2.2.             By Drug Class

9.3.2.2.3.             By End-User

9.3.3.     Canada Therapeutic Drug Monitoring Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Technology

9.3.3.2.2.             By Drug Class

9.3.3.2.3.             By End-User

10.  South America Therapeutic Drug Monitoring Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Technology

10.2.2.  By Drug Class

10.2.2.1.      By Active Ingredient

10.2.3.  By End-User

10.2.4.  By Product

10.2.5.  By Country

10.2.6.  Competition Outlook

10.3.              South America: Country Analysis

10.3.1.  Brazil Therapeutic Drug Monitoring Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Technology

10.3.1.2.2.           By Drug Class

10.3.1.2.3.           By End-User

10.3.2.  Argentina Therapeutic Drug Monitoring Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Technology

10.3.2.2.2.           By Drug Class

10.3.2.2.3.           By End-User

10.3.3.  Colombia Therapeutic Drug Monitoring Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Technology

10.3.3.2.2.           By Drug Class

10.3.3.2.3.           By End-User

11.  Middle East and Africa Therapeutic Drug Monitoring Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Technology

11.2.2.  By Drug Class

11.2.2.1.      By Active Ingredient

11.2.3.  By End-User

11.2.4.  By Product

11.2.5.  By Country

11.2.6.  Competition Outlook

11.3.              MEA: Country Analysis

11.3.1.  South Africa Therapeutic Drug Monitoring Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Technology

11.3.1.2.2.           By Drug Class

11.3.1.2.3.           By End-User

11.3.2.  Saudi Arabia Therapeutic Drug Monitoring Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Technology

11.3.2.2.2.           By Drug Class

11.3.2.2.3.           By End-User

11.3.3.  UAE Therapeutic Drug Monitoring Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Technology

11.3.3.2.2.           By Drug Class

11.3.3.2.3.           By End-User

11.3.4.   Israel Therapeutic Drug Monitoring Market Outlook